Frederique Ph.D. Menzaghi - Dec 21, 2022 Form 4 Insider Report for Cara Therapeutics, Inc. (CARA)

Role
Chief Scientific Off,SVP-R&D
Signature
/s/Darren DeStefano, Attorney-in-Fact
Stock symbol
CARA
Transactions as of
Dec 21, 2022
Transactions value $
-$39,513
Form type
4
Date filed
12/23/2022, 03:54 PM
Previous filing
Apr 5, 2022
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CARA Common Stock Sale -$39.5K -3.51K -2.07% $11.27 166K Dec 21, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units reported in the Form 4 filed with the Securities and Exchange Commission on December 21, 2021, and does not represent a discretionary trade by the Reporting Person.